BlackRock Japan’s Acorda Therapeutics ACOR Stock Holding History

BlackRock Japan’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4	Closed	-$10K	–	1390
2016 Q3	$10K	Sell	4 -1	-20%	-$2.98K	﹤0.01%	1208
2016 Q2	$15K	Sell	5 -4	-44%	-$13K	﹤0.01%	1222
2016 Q1	$30K	Buy	9 +1	+13%	+$4.15K	﹤0.01%	1118
2015 Q4	$42K	Sell	8 -2	-20%	-$8.74K	﹤0.01%	1061
2015 Q3	$31K	Sell	10 -18	-64%	-$69.8K	﹤0.01%	1049
2015 Q2	$112K	Hold	28	–	–	﹤0.01%	953
2015 Q1	$111K	Buy	28 +10	+56%	+$45.8K	﹤0.01%	946
2014 Q4	$87K	Sell	18 -18	-50%	-$77.2K	﹤0.01%	994
2014 Q3	$147K	Buy	36 +5	+16%	+$18.8K	﹤0.01%	893
2014 Q2	$124K	Buy	31 +21	+210%	+$85.6K	﹤0.01%	910
2014 Q1	$44K	Buy	10 +6	+150%	+$24.3K	﹤0.01%	1181
2013 Q4	$14K	Buy	+4	New	+$15.6K	﹤0.01%	1260

Other funds holding ACOR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BlackRock Japan's ACOR Position: Q4 2016 in Review

BlackRock Japan sold out of Acorda Therapeutics (ACOR) in Q4 2016, closing a stake of 4 shares — an estimated $10K sold.

BlackRock Japan first reported a position in ACOR in Q4 2013 and held it in 12 quarters. The position peaked at $147K in Q3 2014. 175 funds tracked by Wall St. Rank hold ACOR as of Q4 2016.

BlackRock Japan reported no remaining Acorda Therapeutics position as of Q4 2016 after selling out during the quarter.
BlackRock Japan sold 4 Acorda Therapeutics shares in Q4 2016, an estimated $10K.
BlackRock Japan first reported a position in Acorda Therapeutics in Q4 2013 and held it in 12 quarters.
BlackRock Japan's Acorda Therapeutics position peaked at $147K in Q3 2014.
175 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.